We are currently in consultation with TGA, and understand that there are a number of shortages including:
- Coumadin 5 mg tablets until end of July
- Coumadin 2 mg tablets until end of April
- Marevan 3 mg tablets until 10 March 2023
TGA are actively working with suppliers and chemists to ensure that appropriate stocks remain. We are aware that some patients are attending multiple pharmacies and that some patients may have to undertake a temporary substitution in either formulation or individual tablet dosage. This may require more frequent monitoring and we have communicated to the media that patients should consult with their prescribing doctor.
We have strongly advocated to TGA the importance of warfarin to many patients, and have requested that they investigate approaches which permit them to communicate to patients where warfarin is accessible.
We’ll keep you posted with any more developments.